Studies of the effects of fragment (25-35) of beta-amyloid peptide on the behavior of rats in a radial maze

Neuroscience and Behavioral Physiology

Volumn 35, Issue 5, 2005, Pages 511-518

  Stepanichev, M Yu ^a   Moiseeva, Yu V ^a   Lazareva, N A ^a   Gulyaeva, N V ^a  

^a INSTITUTE OF HIGHER NERVOUS ACTIVITY AND NEUROPHYSIOLOGY   (Russian Federation)

Author keywords

Beta amyloid peptide (25 35); Learning; Memory; Radial maze

Indexed keywords

AMYLOID BETA PROTEIN[25-35];

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; FEEDING BEHAVIOR; LONG TERM MEMORY; MALE; MAZE TEST; MEMORY CONSOLIDATION; MEMORY DISORDER; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; RAT; TRAINING; WORKING MEMORY;

AMYLOID BETA-PROTEIN; ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FUNCTIONAL LATERALITY; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; REACTION TIME; RETENTION (PSYCHOLOGY); TIME FACTORS;

EID: 18144391180     PISSN: 00970549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11055-005-0086-1     Document Type: Article

References (44)

1. O. S. Mitrokhina, M. Yu. Stepanichev, N. A. Lazareva, et al., "The effects of intracerebroventricular administration of fragment (25-35) of beta-amyloid peptide on the level of lipid peroxidation in rat brain structures and blood," Dokl. Ros. Akad. Nauk., 368, No.5, 711-713 (1999).
2. M. Yu. Stepanichev, N. A. Lazareva, M. V. Onufriev, et al., "The effects of administration of fragment (25-35) of beta-amyloid peptide on behavior in rats," Zh. Vyssh. Nerv. Deyat., 47, No.3, 597-600 (1997).
3. M. Yu. Stepanichev, Yu. V. Moiseeva, and N. V. Gulyaeva, "'Injection' models of Alzheimer's disease: Oxidative stress in the mechanism of toxicity AF64A and β-amyloid peptide in rodents" Neirokhimiya, 19, No.3, 165-175 (2002).
4. M. Yu. Stepanichev, M. V. Onufriev, O. S. Mitrokhina, et al., "Neurochemical, behavioral, and neuromorphological effects of central administration of beta-amyloid peptide (25-35) in rats," Neirokhimiya, 17, No.4, 291-306 (2000).
5. V. V. Trubetskaya, M. Yu. Stepanichev, M. V. Onufriev, et al., "Administration of aggregated beta-amyloid peptide (25-35) induces changes in long-term potentiation in the hippocampus in vivo," Zh. Vyssh. Nerv. Deyat., 51, No.6, 701-704 (2001).
6. E. Abe, F. Casamenti, L. Giovannelli, et al., "Administration of amyloid beta-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo," Brain Res., 636, 162-164 (1994).
7. A. Baddeley, "The fractionation of working memory," Proc. Natl. Acad. Sci. USA, 93, 13468-13472 (1993).
8. G. T. Bartoo, D. Nochlin, D. Chang, et al., "The mean Aβ load in the hippocampus correlates with duration and severity of dementia in subgroups of Alzheimer disease," J. Neuropathol. Exp. Neurol., 56, 531-540 (1997).
9. S. Y. Chen, J. W. Wright, and C. D. Barnes, "The neurochemical and behavioral effects of beta-amyloid peptide (25-35)," Brain Res., 720, 54-60 (1996).
10. J. J. Chrobak, I. Hanin, D. E. Schmechel, and T. J. Walsh, "AF64A-induced working memory impairment: Behavioral, neurochemical and histological correlates," Brain Res., 463, 107-117 (1988).
11. R. F. Cowburn, B. Wiehager, E. Trief, et al., "Effects of β-amyloid-(25-35) peptides on radioligand binding to excitatory amino acid receptors and voltage-dependent calcium channels: Evidence for a selective affinity for glutamate and glycine recognition sites of the NMDA receptor," Neurochem. Res., 22, 1437-1442 (1997).
12. W. K. Cullen, Y.-H. Suh, R. Anwyl, and M. J. Rowan, "Block of LTP in rat hippocampus in vivo by β-amyloid precursor protein fragments," Neuroreport, 8, 3213-3217 1997
13. S. Delobette, A. Privat, and T. Maurice, "In vitro aggregation facilitates beta-amyloid peptide-(25-35)-induced amnesia in the rat," Eur. J. Pharmacol., 319, 1-4 (1997).
14. D. W. Dickson, H. A. Crystal, L. A. Mattiace, et al., "Identification of normal and pathological aging in prospectively studied nondemented elderly humans," Neurobiol. Aging, 13, 179-189 (1992).
15. L. Giovanelli, F. Casamenti, C. Scali, et al., "Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis," Neurosci., 66, 781-792 (1995).
16. N. V. Gulyaeva I. V. Victorov M. and Yu. Stepanichev 1998 "Intracerebroventricular administration of beta-amyloid peptide (25-35) induces oxidative stress and neurodegeneration in rat brain" in: Progress in Alzheimer's and Parkinson's Diseases, A. Fisher (eds.) Plenum Press New York 89-98
17. T. Harkany, J. Mulder, M. Sasvan, et al, "N-methyl-D-aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis neurons against β-amyloid neurotoxicity,β Neurobiol. Dis., 6, 109-121 1999
18. K. Hsiao, P. Chapman, S. Nilsen, et al., "Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice," Science, 274, 99-102 (1996).
19. R. Katzman, R. Terry, R. DeTeresa, et al., "Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques," Ann. Neurol., 23, 138-144 (1988).
20. H. Lin, R. Bhatia, and R. Lal, "Amyloid (beta) protein forms ion channels: Implications for Alzheimer's disease pathophysiology," FASEB J., 15, 2433-2444 (2001).
21. Y. Luo, D. B. Hawyer, K. Iwasaki, et al., "Physiological levels of β-amyloid peptide stimulate protein kinase C in PC12 cells" Brain Res., 769, 287-295 (1997).
22. M. P. Mattson, "Modification of ion homeostasis by lipid peroxidation: Roles in neuronal degeneration and adaptive plasticity," Trends Neurosci., 21, 53-57 (1998).
23. 2+ homeostasis in Alzheimer's disease," Trends. Neurosci., 16, 409-414 (1993).
24. T. Maurice, B. P. Lockart, and A. Privat, "Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction," Brain Res., 706, 181-193 (1996).
25. M. P. McDonald, E. E. Dahl, Y. B. Overmeier, et al., "Effects of an exogenous β-amyloid peptide on retention for spatial learning," Behav. Neural. Biol., 62, 60-67 (1994).
26. M. P. McDonald, E. E. Dahl, Y. B. Overmeier, et al., "Reversal of β-amyloid-induced retention deficit after exposure to training and state cues" Neurobiol. Learn. Mem., 65, 35-47 (1996).
27. M. P. McDonald and Y. B. Overmeier, "Present imperfect: A critical review of animal models of mnemonic impairments in Alzheimer's disease," Neurosci. Biobehav. Rev., 22, 99-120 (1998).
28. R. G. M. Morris, "Episodic-like memory in animals: Psychological criteria, neural mechanisms and the value of episodic-like tasks to investigate animal models of neurodegenerative disease," Phil. Trans. Roy. Soc. Lond., 356, 1453-1463 (2001).
29. J. Naslund, V. Haroutunian, R. Mohs, et al., "Correlation between levels of amyloid beta-peptide in the brain and cognitive decline," J. Amer. Med. Assoc., 283, 1571-1577 (2000).
30. A. Nitta A. Itoh T. Hasegawa T. Nabeshima "β-amyloid protein-induced Alzheimer's disease animal model" Neurosci. Lett., 289, 63-66 (1994).
31. A. Olariu, M. H. Tran, K. Yamada, et al., "Memory deficits and increased emotionality induced by beta-amyloid (25-35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampus" J. Neural Transm., 108, 1065-1079 (2001).
32. D. S. Olton, "Spatial memory," Sci. Amer., 236, 82-98 (1977).
33. S. O'Mahony, T. Harkany, A. A. M. Rensink, et al., "β-amyloid-induced cholinergic denervation correlates with enhanced nitric oxide synthase activity in rat cerebral cortex: Reversal by NMDA receptor blockade," Brain Res. Bull. 45 405-411 1998
34. G. Paxinos and C. Watson 1982 The Rat Brain in Stereotaxic Coordinates Academic Press Sidney
35. C. J. Pike, D. Brudick, A. J. Walencevicz, et al., "Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state," J. Neurosci., 13, 1676-1687 (1993).
36. D. J. Selkoe, "Alzheimer's disease: Genes, proteins, and therapy," Physiol. Rev., 81, 741-766 (2001).
37. A. Stephan, S. Laroche, and S. Davis, "Generation of aggregated β-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits," J. Neurosci., 21, 5703-5714 (2001).
38. W. Sweeney J. Luedtke M.P. McDonald J.B. Overmeier "Intrahippocampal β-amyloid impairs win-shift radial maze performance in rats,β Neurobiol. Learn. Mem., 68, 97-101 (1997).
39. J. P. Terranova, J. P. Kan, J. J. Storme, et al., "Administration of amyloid beta-peptides in the rat medial septum causes memory deficits: Reversal by SR 57746A, a non-peptide neurotrophic compound," Neurosci. Lett., 213, 79-82 (1996).
40. L. Tong P.L. Thornton R. Balazs C.W. Cotman "β-Amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signalling in neurons at concentrations in which cell survival is not compromised," J. Biol. Chem., 276, 17301-17306 (2001).
41. M.H. Tran, K. Yamada, A. Olariu, et al., "Amyloid β-peptide induces nitric oxide production in rat hippocampus: Association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors," FASEB J., 15, 1407-1409 (2001).
42. M.A. Westerman D. Cooper-Blacketer A. Mariash et al. "The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer's disease," J. Neurosci., 22, 1858-1867 (2002).
43. Y. Yamaguchi and S. Kawashima, "Effects of amyloid-β-(25-35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat," Eur. J. Pharmacol., 412, 265-272 (2001).
44. B.A. Yankner L.K. Duffy and D.A. Kirschner "Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides," Science, 250, 279-282 (1990).